Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06778148 · ClinicalTrials.gov registry record · NA
Abridge AI Pilot Test
A NA study of Clinician Experience and Clinician Burnout, sponsored by University of Colorado, Denver.
- Active
- Registry status
- NA
- Development phase
- 232
- Enrollment target
- 1
- Study location
NCT06778148: Active NA study of Clinician Experience and Clinician Burnout, sponsored by University of Colorado, Denver.
NCT06778148 is a NA study of Clinician Experience and Clinician Burnout that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 232 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06778148, a NA study of Clinician Experience and Clinician Burnout, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 232 participants
- Enrollment target
- 1
- Study location
Study Summary
We are piloting a new technology (Abridge) that uses artificial intelligence to listen to clinician-patient office visits and then document the interaction in the electronic health record.
Primary Outcome
Validated measure collected by survey. Reference: https://pmc.ncbi.nlm.nih.gov/articles/PMC3475833/
Conditions Studied
Interventions
- OTHER Ambient AI for clinician documentation
Study Locations (1)
Colorado
- UCHealth - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2025-01-13 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT06778148 still lists
NCT06778148 is an interventional study that assigns participants to a tested intervention. The registered 232 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 2 conditions, with Clinician Experience appearing as the primary indexed condition, and to 1 intervention - of which Ambient AI for clinician documentation is the first listed.
NCT06778148 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06778148 about?
NCT06778148 is a clinical study titled "Abridge AI Pilot Test". We are piloting a new technology (Abridge) that uses artificial intelligence to listen to clinician-patient office visits and then document the interaction in the electronic health record.
What is the current status of trial NCT06778148?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 232 participants. The study started on 2025-01-13. Estimated completion is 2025-12-31.
What conditions does trial NCT06778148 study?
This clinical trial studies the following conditions: Clinician Experience, Clinician Burnout.
What interventions are being tested in trial NCT06778148?
The interventions under investigation include: Ambient AI for clinician documentation (OTHER).
Who is sponsoring clinical trial NCT06778148?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06778148 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06778148's enrollment target sits among peer trials
232 463rd of 2000 higher than 1,536 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01356290 · 232 participants · Phase 2
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- NCT04753359 · 232 participants · NA
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
- NCT04770870 · 232 participants · NA
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
- NCT05948943 · 232 participants · Phase 2
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI